These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 8489239)
41. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539 [TBL] [Abstract][Full Text] [Related]
42. Rat liver cytochrome P450 2B3: structure of the CYP2B3 gene and immunological identification of a constitutive P450 2B3-like protein in rat liver. Jean A; Reiss A; Desrochers M; Dubois S; Trottier E; Trottier Y; Wirtanen L; Adesnik M; Waxman DJ; Anderson A DNA Cell Biol; 1994 Aug; 13(8):781-92. PubMed ID: 8068203 [TBL] [Abstract][Full Text] [Related]
43. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Brady JF; Li DC; Ishizaki H; Yang CS Cancer Res; 1988 Nov; 48(21):5937-40. PubMed ID: 3167846 [TBL] [Abstract][Full Text] [Related]
44. Regulation of cytochrome P450 2B1/2 mRNAs by Kepone (chlordecone) and potent estrogens in primary cultures of adult rat hepatocytes on Matrigel. Kocarek TA; Schuetz EG; Guzelian PS Toxicol Lett; 1994 Apr; 71(2):183-96. PubMed ID: 7513451 [TBL] [Abstract][Full Text] [Related]
45. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1. Shu L; Hollenberg PF Carcinogenesis; 1997 Apr; 18(4):801-10. PubMed ID: 9111218 [TBL] [Abstract][Full Text] [Related]
46. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine. Murray M Biochem Pharmacol; 1992 Sep; 44(6):1219-22. PubMed ID: 1417944 [TBL] [Abstract][Full Text] [Related]
47. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily. Kim SG; Reddy SL; States JC; Novak RF Mol Pharmacol; 1991 Jul; 40(1):52-7. PubMed ID: 1857340 [TBL] [Abstract][Full Text] [Related]
48. Different activation patterns of rat xenobiotic metabolism genes by two constituents of garlic. Zhang P; Noordine ML; Cherbuy C; Vaugelade P; Pascussi JM; Duée PH; Thomas M Carcinogenesis; 2006 Oct; 27(10):2090-5. PubMed ID: 16679304 [TBL] [Abstract][Full Text] [Related]
49. Effects of beta-ionone on the expression of cytochrome P450s and NADPH-cytochrome P450 reductase in Sprague Dawley rats. Jeong TC; Gu HK; Chun YJ; Yun CH; Han SS; Roh JK Chem Biol Interact; 1998 Jul; 114(1-2):97-107. PubMed ID: 9744558 [TBL] [Abstract][Full Text] [Related]
50. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. Fukao T; Hosono T; Misawa S; Seki T; Ariga T Food Chem Toxicol; 2004 May; 42(5):743-9. PubMed ID: 15046820 [TBL] [Abstract][Full Text] [Related]
51. Correlation between alterations in nucleosomal organization of LINEs in the promoter of cytochrome P450 2B1/2 gene and induction of CYP 2B1/2B2 mRNA expression by phenobarbitone in rat liver. Dey I; Rath PC DNA Cell Biol; 2005 Jun; 24(6):359-70. PubMed ID: 15941388 [TBL] [Abstract][Full Text] [Related]
52. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane. Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699 [TBL] [Abstract][Full Text] [Related]
53. Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan). Baldwin SJ; Bramhall JL; Ashby CA; Yue L; Murdock PR; Hood SR; Ayrton AD; Clarke SE Drug Metab Dispos; 2006 Jun; 34(6):1063-9. PubMed ID: 16531474 [TBL] [Abstract][Full Text] [Related]
54. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5. John GH; Hasler JA; He YA; Halpert JR Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Brady JF; Ishizaki H; Fukuto JM; Lin MC; Fadel A; Gapac JM; Yang CS Chem Res Toxicol; 1991; 4(6):642-7. PubMed ID: 1807447 [TBL] [Abstract][Full Text] [Related]
56. Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes. Haber D; Siess MH; Canivenc-Lavier MC; Le Bon AM; Suschetet M J Toxicol Environ Health; 1995 Apr; 44(4):423-34. PubMed ID: 7723075 [TBL] [Abstract][Full Text] [Related]
57. Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain. Parmar D; Dhawan A; Seth PK Mol Cell Biochem; 1998 Dec; 189(1-2):201-5. PubMed ID: 9879672 [TBL] [Abstract][Full Text] [Related]
58. Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro. Bars RG; Bell DR; Elcombe CR Biochem Pharmacol; 1993 May; 45(10):2045-53. PubMed ID: 7685601 [TBL] [Abstract][Full Text] [Related]
59. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide. Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044 [TBL] [Abstract][Full Text] [Related]
60. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]